Cargando…
Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated transcription factor that belongs to the nuclear hormone receptor superfamily. PPARγ is essential in adipocyte differentiation from precursor cells. Its antitumorigenic effects are reported in certain malignan...
Autores principales: | Takeuchi, Akihiko, Yamamoto, Norio, Shirai, Toshiharu, Hayashi, Katsuhiro, Miwa, Shinji, Munesue, Seiichi, Yamamoto, Yasuhiko, Tsuchiya, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939636/ https://www.ncbi.nlm.nih.gov/pubmed/27401457 http://dx.doi.org/10.1186/s12885-016-2524-6 |
Ejemplares similares
-
Anti‐tumor effects of a nonsteroidal anti‐inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator‐activated receptor gamma and suppressing matrix metalloproteinase‐2 expression
por: Higuchi, Takashi, et al.
Publicado: (2018) -
Current and Emerging Targets in Immunotherapy for Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2019) -
Successful correction of tibial bone deformity through multiple surgical procedures, liquid nitrogen-pretreated bone tumor autograft, three-dimensional external fixation, and internal fixation in a patient with primary osteosarcoma: a case report
por: Takeuchi, Akihiko, et al.
Publicado: (2015) -
Treatment outcomes of the simple bone cyst: A comparative study of 2 surgical techniques using artificial bone substitutes
por: Higuchi, Takashi, et al.
Publicado: (2018) -
Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019)